Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The effects of mutant Ras proteins on the cell signalome
Tamás Takács, Gyöngyi Kudlik, Anita Kurilla, et al.
Cancer and Metastasis Reviews (2020) Vol. 39, Iss. 4, pp. 1051-1065
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Tumor biomarkers for diagnosis, prognosis and targeted therapy
Yue Zhou, Lei Tao, Jiahao Qiu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 160
Drugging KRAS: current perspectives and state-of-art review
Kaushal Parikh, Giuseppe Luigi Banna, Stephen V. Liu, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 88
The Crossroads between RAS and RHO Signaling Pathways in Cellular Transformation, Motility and Contraction
Olga Soriano, Marta Alcón-Pérez, Miguel Vicente‐Manzanares, et al.
Genes (2021) Vol. 12, Iss. 6, pp. 819-819
Open Access | Times Cited: 62
Targeted therapy for lung cancer: Beyond EGFR and ALK
Mercedes Herrera, Cristina Serrano‐Gómez, Helena Bote, et al.
Cancer (2023) Vol. 129, Iss. 12, pp. 1803-1820
Closed Access | Times Cited: 34
Molecular pathways in reproductive cancers: a focus on prostate and ovarian cancer
Ayodeji Folorunsho Ajayi, Mega O. Oyovwi, Oyedayo Phillips Akano, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Mutated HRAS Activates YAP1–AXL Signaling to Drive Metastasis of Head and Neck Cancer
Sankar Jagadeeshan, Manu Prasad, Mai Badarni, et al.
Cancer Research (2023) Vol. 83, Iss. 7, pp. 1031-1047
Open Access | Times Cited: 18
Akt enhances the vulnerability of cancer cells to VCP/p97 inhibition-mediated paraptosis
Dong Min Lee, In Young Kim, Hong Jae Lee, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Regulation of Cancer Metastasis by TRAIL/Death Receptor Signaling
You-Take Oh, Shi‐Yong Sun
Biomolecules (2021) Vol. 11, Iss. 4, pp. 499-499
Open Access | Times Cited: 37
The storm of NGS in NSCLC diagnostic-therapeutic pathway: How to sun the real clinical practice
Giovanna De Maglio, Giulia Pasello, Mariella Dono, et al.
Critical Reviews in Oncology/Hematology (2021) Vol. 169, pp. 103561-103561
Open Access | Times Cited: 34
Identification of Dietary Bioflavonoids as Potential Inhibitors against KRAS G12D Mutant—Novel Insights from Computer-Aided Drug Discovery
Prasanna Srinivasan Ramalingam, Purushothaman Balakrishnan, Senthilnathan Rajendran, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 3, pp. 2136-2156
Open Access | Times Cited: 16
Recent advances in the development of inhibitors targeting KRAS-G12C and its related pathways
Dan Zhao, Yu Liu, Fengchao Yi, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115698-115698
Closed Access | Times Cited: 13
Targeting KRAS in pancreatic cancer: Emerging therapeutic strategies
Sajid Khan, Vivekananda Budamagunta, Daohong Zhou
Advances in cancer research (2023), pp. 145-184
Closed Access | Times Cited: 12
Design and development of dual targeting CAR protein for the development of CAR T-cell therapy against KRAS mutated pancreatic ductal adenocarcinoma using computational approaches
Prasanna Srinivasan Ramalingam, T. Premkumar, Vino Sundararajan, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
The role of metabolic ecosystem in cancer progression — metabolic plasticity and mTOR hyperactivity in tumor tissues
Anna Sebestyén, Titanilla Dankó, Dániel Sztankovics, et al.
Cancer and Metastasis Reviews (2021) Vol. 40, Iss. 4, pp. 989-1033
Open Access | Times Cited: 25
EGF Induces Migration Independent of EMT or Invasion in A549 Lung Adenocarcinoma Cells
Karin Schelch, Lisa Vogel, Anja Schneller, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 24
Discovery of Orally Bioavailable SOS1 Inhibitors for Suppressing KRAS-Driven Carcinoma
Huan He, Yu Zhang, Juan Xu, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 19, pp. 13158-13171
Closed Access | Times Cited: 19
An overview of PROTACs targeting KRAS and SOS1 as antitumor agents
Zang Chao Han, Qiaolin Wu, H. Surya Prakash Rao, et al.
Bioorganic & Medicinal Chemistry Letters (2025), pp. 130283-130283
Closed Access
An extracellular vesicular mutant KRAS‐associated protein complex promotes lung inflammation and tumor growth
Mukesh K. Sriwastva, Yun Teng, Jingyao Mu, et al.
Journal of Extracellular Vesicles (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 8
Potential biomarkers uncovered by bioinformatics analysis in sotorasib resistant-pancreatic ductal adenocarcinoma
Prasanna Srinivasan Ramalingam, A. Priyadharshini, Isaac Arnold Emerson, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 8
In Silico Analysis of nsSNPs of Human KRAS Gene and Protein Modeling Using Bioinformatic Tools
Duoduo Xu, Qiqi Shao, Chen Zhou, et al.
ACS Omega (2023) Vol. 8, Iss. 14, pp. 13362-13370
Open Access | Times Cited: 7
Molecular Pathways and Druggable Targets in Head and Neck Squamous Cell Carcinoma
Farzaneh Kordbacheh, Camile S. Farah
Cancers (2021) Vol. 13, Iss. 14, pp. 3453-3453
Open Access | Times Cited: 16
Anticancer and anti-metastasis activity of 1,25 dihydroxycholecalciferols and genistein in MCF-7 and MDA-MB-231 breast cancer cell lines
Fatema Suliman Alatawi, Uzma Faridi
Heliyon (2023) Vol. 9, Iss. 11, pp. e21975-e21975
Open Access | Times Cited: 6
p-MEK expression predicts prognosis of patients with adenocarcinoma of esophagogastric junction (AEG) and plays a role in anti-AEG efficacy of Huaier
Yuan Li, Shaowei Mo, Zhiyuan Xu, et al.
Pharmacological Research (2021) Vol. 165, pp. 105411-105411
Closed Access | Times Cited: 14
Predicting IHC staining classes of NF1 using features in the hematoxylin channel
Wei Zhang, Mei Yee Koh, Deepika Sirohi, et al.
Journal of Pathology Informatics (2023) Vol. 14, pp. 100196-100196
Open Access | Times Cited: 5
YB-1 activating cascades as potential targets in KRAS-mutated tumors
Shayan Khozooei, Soundaram Veerappan, Mahmoud Toulany
Strahlentherapie und Onkologie (2023) Vol. 199, Iss. 12, pp. 1110-1127
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top